Yali Bio
7 known investors
Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.
Investors · 7
First In VenturesMiddletown · $50K – $200K
FTW VenturesSan Francisco · $100K – $500K
S2G InvestmentsChicago · $1M – $5M
CRCM Venturesreported · 2 sourcesSan Francisco · $100K – $5M
Third Kind Venture Capitalreported · 2 sourcesNew York · $50K – $5M
Also in the syndicate · 2
Essential CapitalleadThird Kind Capital
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingMar 2022
Essential Capital (lead), CRCM Ventures, First-in Ventures, FTW Ventures, S2G Ventures, Third Kind Capital
Source ↗ - Undisclosed amountseed roundFeb 2022
Essential Capital (lead), CRCM Ventures, First-in Ventures, FTW Ventures, S2G Ventures, Third Kind Venture Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $370.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Yali Bio do?
- Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.
- Who are Yali Bio's investors?
- Yali Bio's investors include First In Ventures, FTW Ventures, S2G Investments, CRCM Ventures, Third Kind Venture Capital.